Form D · Biotechnology
HDL THERAPEUTICS, INC.
Vero Beach, FL · CIK 0001569047
Offering snapshot reported Jul 10, 2023 · SEC filing
- Reported sold
- $1.27M Offering amount: $7M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 22, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 10, 2023 | Initial | $1,270,074 | No comparison | 15 | SEC filing |
| Mar 4, 2021 | Initial | $3,355,237 | No comparison | 31 | SEC filing |
| Oct 3, 2019 | Initial | $3,000,019 | No comparison | 34 | SEC filing |
| May 10, 2017 | Amendment | $7,195,065 | $5,708,455vs Sep 14, 2016 | 57 | SEC filing |
| Sep 14, 2016 | Initial | $1,486,610 | No comparison | 13 | SEC filing |
| Dec 31, 2014 | Initial | $2,045,000 | No comparison | 14 | SEC filing |
| Feb 13, 2013 | Initial | $925,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-486274
Series X Preferred Shares
Source: Form D, filed Jul 10, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dane Andreeff | Director |
| Bryan Brewer | Executive |
| Michael Matin | Executive |
| Gregg Sessa | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
601 21 St Street Suite 300
Vero Beach, FL, 32960
Vero Beach, FL, 32960